4Life Transfer Factor RioVida®

Ride the River of Life

Buy now!

4Life Transfer Factor® RioVida® Tri-Factor® Formula is a liquid dietary supplement in the world that features 4Life Transfer Factor® for immune system support, and antioxidant-rich superfruits, including: açaí, pomegranate, blueberry, and elderberry.*

Primary Supports

Immune system, Healthy aging, Antioxidant, Overall wellness*

Secondary Supports

Brain health, Heart health, and Energy*

Contains Tri-Factor® Formula for immune system support*

  • Tri-Factor Formula: made from cow colostrum and egg yolk that can provide immune system-boosting benefits.*

Get your vitamin C

  • RioVida contains vitamin C, amino acids, fatty acids, and polyphenols to support overall wellness.*

Fabulous fruits

  • The RioVida blend has apple, purple grape, blueberry, açaí, pomegranate, and elderberry fruit juices from concentrate.
  • These delicious fruits provide mouthwatering flavor.
  • These antioxidant-rich superfruits help protect the body from naturally occurring free radicals.*

Experience RioVida

  • Supports the immune system’s natural ability to recognize, respond to, and remember potential health threats with 600 mg of 4Life Transfer Factor*
  • Has a mouthwatering flavor
  • Includes a propriety combination of antioxidant-rich natural fruit juices, including açaí, pomegranate, blueberry, and elderberry*
  • Contains vitamin C, amino acids, fatty acids, and polyphenols
  • Contains 4Life Transfer Factor.*

  • Why did the RioVida bottle change?
    This bottle shape improves RioVida’s durability as it is shipped all over the world.
  • Do I still get the same amount of product?
    Yes, you still get the same amount of RioVida juice in each bottle: 16.9 oz, or 500 mL per bottle.
  • Will the price increase?
    There will be no price increase with this new RioVida bottle.
  • Are there any formula changes?
    The RioVida formula has not changed.
  • When will I get this new RioVida bottle?
    The new RioVida bottle should begin shipping in January 2024 for the U.S. and soon after for other markets.